Web Links: Medical science

Affiliations

REACTION is affilliated with these programs and organisations:

REACTION is delivering better and more efficient healthcare services in Europe, thus supporting the Commissions activities in ICT for Health: eHealth.

The REACTION platform allows for the creation of inclusive applications with accessibility for all. The project supports the Commissions campaign: eInclusion - be part of it!

Sign In

Forgot Password?

The REACTION project is a 4-year project started in 2010. It is partly funded by the European Commission under the 7th Framework Programme in the area of Personal Health Systems under Grant Agreement no. 248590

Impressum

Privacy

Newsletters

Read previous issues of our newsletter here:
April 2014
August 2013
June 2012
August 2011
April 2011
November 2010

Most Read...

Articles

In-hospital saf...	186506
Reaction in the...	113415
Medical background	106228
Project overview	105774
Project methodo...	79764

News

Research award ...	57609
IST-Africa Call...	54528
REACTION at one...	52500
REACTION videos...	49521
REACTION online...	47904

Popular Downloads

REACTION brochure	30251
Design of a mobil...	13067
D9-4 Healthcare e...	11224
D9-2 Regulatory f...	10081
2_Regulatory Fram...	6605

Facebook

Join the discussion on EC eHealth at Facebook!

Oh no! Where's the JavaScript?
Your Web browser does not have JavaScript enabled or does not support JavaScript. Please enable JavaScript on your Web browser to properly view this Web site, or upgrade to a Web browser that does support JavaScript.

A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes
Automated control of blood glucose (BG) concentration is a long-sought goal for type 1 diabetes therapy. We have developed a closed-loop control system that uses frequent measurements of BG concentration along with subcutaneous delivery of both the fast-acting insulin analog lispro and glucagon (to imitate normal physiology) as directed by a computer algorithm. Firas H. El-Khatib et.al., Department of Biomedical Engineering, Boston University, Boston
Date Added: 18-05-2010	Visits: 4443

The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine supp
The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial.OBJECTIVE: To demonstrate that Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support significantly improves HbA(1c) in poorly controlled type 1 diabetic patients.
Date Added: 28-04-2011	Visits: 5741

Telemedicine Toolkit
COCIR, the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry, has collected a large number of clinical studies providing evidence of medical outcome of telemedicine solutions. The list can be found in the COCIR document.
Date Added: 24-01-2012	Visits: 2471